EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Fluoropyrimidines trigger decay of hypomodified tRNA in yeast

Katharina Görlitz, Larissa Bessler, Mark Helm iD, Raffael Schaffrath iD, Roland Klassen iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkae341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Katharina Görlitz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology, Department of Microbiology, Universität Kassel, Kassel 34132, Germany. Hauptthemen laut MEDLINE: Flucytosine, Fluorouracil, RNA, Transfer, Saccharomyces cerevisiae. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: LOEWE, Deutsche Forschungsgemeinschaft, University of Kassel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic fluoropyrimidines 5-fluorouracil (5-FU) and 5-fluorocytosine (5-FC) are in long use for treatment of human cancers and severe invasive fungal infections, respectively. 5-Fluorouridine triphosphate represents a bioactive metabolite of both drugs and is incorporated into target cells’ RNA. Here we use the model fungus Saccharomyces cerevisiae to define fluorinated tRNA as a key mediator of 5-FU and 5-FC cytotoxicity when specific tRNA methylations are absent. tRNA methylation deficiency caused by loss of Trm4 and Trm8 was previously shown to trigger an RNA quality control mechanism resulting in partial destabilization of hypomodified tRNAValAAC. We demonstrate that, following incorporation into tRNA, fluoropyrimidines strongly enhance degradation of yeast tRNAValAAC lacking Trm4 and Trm8 dependent methylations. At elevated temperature, such effect occurs already in absence of Trm8 alone. Genetic approaches and quantification of tRNA modification levels reveal that enhanced fluoropyrimidine cytotoxicity results from additional, drug induced uridine modification loss and activation of tRNAValAAC decay involving the exonuclease Xrn1. These results suggest that inhibition of tRNA methylation may be exploited to boost therapeutic efficiency of 5-FU and 5-FC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlucytosineFluorouracilRNA, TransferSaccharomyces cerevisiaeExoribonucleasesMethylationRNA StabilitySaccharomyces cerevisiae ProteinstRNA MethyltransferasesUridine

Substanzen

ExoribonucleasesFlucytosineFluorouracilRNA, TransferSaccharomyces cerevisiae ProteinstRNA MethyltransferasesUridineXRN1 protein, S cerevisiaeNCL1 protein, S cerevisiaetRNA (guanine-N7-)-methyltransferase

Autor:innen und Institutionen

  • Institute of Biology, Department of Microbiology, Universität Kassel, Kassel 34132, Germany.
  • Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-Universität Mainz, Mainz 55128, Germany.

ORCID-Profile: Mark Helm, Raffael Schaffrath, Roland Klassen

Förderung

  • LOEWE
  • Deutsche Forschungsgemeinschaft
  • University of Kassel

Zitieren

APA

Görlitz, K., Bessler, L., Helm, M., Schaffrath, R., & Klassen, R. (2024). Fluoropyrimidines trigger decay of hypomodified tRNA in yeast. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae341

Vancouver

Görlitz K, Bessler L, Helm M, Schaffrath R, Klassen R. Fluoropyrimidines trigger decay of hypomodified tRNA in yeast. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae341

BibTeX
@article{Grlitz2024,
  author = {Görlitz, Katharina and Bessler, Larissa and Helm, Mark and Schaffrath, Raffael and Klassen, Roland},
  title = {Fluoropyrimidines trigger decay of hypomodified tRNA in yeast},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkae341}
}
Kostenlos starten →